Acute paranoid psychosis as sole clinical presentation of hepatic artery thrombosis after living donor liver transplantation
© Goralczyk et al; licensee BioMed Central Ltd. 2010
Received: 29 July 2009
Accepted: 22 February 2010
Published: 22 February 2010
Hepatic artery thrombosis is a devastating complication after orthotopic liver transplantation often requiring revascularization or re-transplantation. It is associated with considerably increased morbidity and mortality. Acute cognitive dysfunction such as delirium or acute psychosis may occur after major surgery and may be associated with the advent of surgical complications.
Here we describe a case of hepatic artery thrombosis after living-donor liver transplantation which was not preceded by signs of liver failure but rather by an episode of acute psychosis. After re-transplantation the patient recovered without sequelae.
This case highlights the need to remain cautious when psychiatric disorders occur in patients after liver transplantation. The diagnostic procedures should not be restricted to medical or neurological causes of psychosis alone but should also focus vascular complications related to orthotopic liver transplantation.
Hepatic artery thrombosis (HAT) is the most frequent arterial complication in orthotopic liver transplantation (OLT) occurring in 2.5-6.8% of adult transplant recipients including adult living donor liver transplant recipients [1–3] with an increased incidence in pediatric and ABO-incompatible liver transplantation [4, 5]. The clinical presentation of HAT varies depending on the time of onset after transplantation. Severe acidosis, fever, systematic inflammatory response syndrome, or hepatic failure may ensue in early HAT (less than one month after OLT), whereas presentation of late HAT may vary from biliary complications such as recurrent biliary sepsis and stenotic lesions of the biliary tract, to an asymptomatic clinical picture with a mild elevation of serum transaminases and bilirubin levels [2, 6]. HAT may thus be indicated by elevated serum transaminases, prolonged prothrombin time, or elevated total bilirubin and may be confirmed by doppler ultrasonography or angiography. Although in approximately 47% HAT requires re-OLT, cases without progressive allograft failure arterial flow may be resolved by fibrinolysis, interventional treatment, or surgical thrombectomy . Mortality of HAT may vary from 55.6% (early HAT) to 15% (late HAT) . The most common cause for HAT is surgical technique but hemodynamic or immunologic factors, such as reperfusion injury, hypercoagulation, and viral infections have also been recognized [1, 7]. Risk factors for HAT include the number of allografts, cytomegalovirus (CMV) infection status, high recipient/donor weight ratio, biopsy proven rejection, and combination of female donor and male recipient .
Characteristics of donor and recipient.
A Rh pos.
A Rh pos.
> 1000 mlU/ml
< 10 mIU/ml
The donor underwent standard right lobectomy with preservation of the middle vein. In the recipient a standard total hepatectomy was performed, but due to successive intimal dissection of the hepatic and celiac artery complex arterial reconstruction was necessary. Due to the small diameter of the donor hepatic artery a direct anastomosis to the recipient supraceliac aorta was not feasible so an allogenic iliac artery conduit was required. The interposition graft was obtained from a heart-beating donor of a previous OLT and stored in histidine-tryptophane-ketoglutarate solution at +4°C for 10 days. Anastomosis of the bile duct was performed by duct-to-duct anastomosis to the donor right hepatic duct remnant.
At the time of transplantation the patient received induction immunosuppression consisting of 500 mg methylprednisolone and 20 mg basiliximab, the latter was repeated on the 4th post-operative day (POD). Immunosuppression was maintained with oral mycophenolat mofetil from the first POD at 2 × 1 g daily and oral prednisolone with an initial daily dose of 75 mg. The latter was tapered by 5 mg every two days. On the 5th POD oral tacrolimus was added to the immunosuppressive regimen starting with 0.5 mg on the first day and increasing daily dose by 1 to 2 mg to achieve trough plasma level of 4-10 μ g per liter. After surgery the recipient received continuous intravenous infusion of 5000 units of unfractioned heparin per day for anticoagulation. For prevention of (re-)infection the patient also received 103 units of hepatitis B immunglobuline at reperfusion and intravenous infusion of piperacillin/tazobactam at surgery until the 3rd POD but no antimycotics or prophylactic CMV therapy (both donor and recipient had experienced CMV infection).
In the postoperative course serum transaminases peaked on the first and 4th POD but then decreased continuously as prothrombin time increased (coagulation factors were not substituted). Albeit a gradual increase in total bilirubin plasma levels only a mild graft dysfunction was suspected because bile flow over the T-drain increased. Daily doppler sonography of hepatic vessels showed unaltered graft perfusion. Overall the patient had an uncomplicated postoperative without signs for infection or organ dysfunction. The clinical course and laboratory findings did show mild a graft dysfunction but neither rejection nor acute graft failure were indicated.
On the 9th POD the patient suffered from acute paranoid psychosis, being alert but agitated and physically aggressive. He was mistrustful and afraid of being harmed by people around him. The patient became unmanageable and had to be sedated with an intramuscular injection of 5 mg haloperidol and an intravenous injection of 20 mg diazepam. Due to this unusual presentation of postoperative delirium a diagnostic workup was initiated. Patent hepatic artery could not be shown in doppler sonography and subsequent angiography. Explorative laparotomy on the same day revealed a complete thrombosis of the donor hepatic artery and gross ischemic infarction in all liver segments. Because progression of infarction and subsequent graft loss was to be expected the patient was placed on the transplant waiting list for re-OLT.
Here we describe a case of HAT after LDLT preceded not by signs of an liver failure but by acute paranoid psychosis. At transplantation the patient required a complex arterial reconstruction with an interposition graft which is a known risk factor for HAT [2, 8]. Whether supraceliac or infrarenal placement of the interposition graft is beneficial remains equivocal [1, 9]. LDLT itself has also been implied to be a risk factor for HAT, but Hatano et al could show increased incidence of HAT only in ABO-incompatible grafts . In the described patient we observed a mild graft dysfunction indicated by increasing bilirubin in the first week after LDLT but accompanied by decreasing transaminases and an increasing synthetic liver function. Daily doppler sonography showed patent vessels until he suffered from acute psychosis on the 9th postoperative day.
Psychiatric disorders are not uncommon in the postoperative course of the liver transplant patient . Like other patients undergoing major surgery, transplant patients may suffer from postoperative delirium. The cause of delirium is multifactorial, including predisposing factors (age, primary disease), medical/surgical factors (length of surgery, use of a cardiopulmonary bypass, water-electrolyte imbalances, sepsis, etc), and postoperative emotional stress, like prolonged sleep deprivation, use of physical restraints, and pain [11, 12]. In the described patient postoperative delirium was unlikely because after surgery delirium typically evolves immediately after emergence from general anaesthesia or, after a lucid interval, in the first 72 hours .
Psychiatric disorders may also be drug induced. Immunosuppressive drugs like tacrolimus and corticosteroids are known causative agents of psychiatric reactions [14–16]. Neurotoxic effects are dose dependent and occur in the early phase after initiation, e.g. within the first week [14, 16]. In our patient induction of the described psychiatric symptoms by immunosuppressants was also unlikely because the psychosis occurred after the first week and doses were low, i. e., 5 ng/ml tacrolimus on the 9th postoperative day (see also Figure 1). After re-transplantation he received tacrolimus and prednisolone again without any sign of recurrence of the psychiatric disorder.
Because of elevated bilirubin we also suspected impaired graft function could cause acute psychosis in our patient. In chronic liver failure manifestations of encephalopathy are common and may reach from mild obtundation with dementia and movement disorders to deep coma . In the early phase of acute liver failure agitation, delusional ideas, and hyperkinesis are also common until coma finally ensues . Although typical laboratory findings of acute liver failure are common, only moderate alteration, as seen in our patient, is not an exclusion criterion . In our patient ammonia was also not elevated but in patients with more advanced hepatocellular dysfunction the level of ammonia is only poorly correlated with the severity of hepatic encephalopathy . Besides the accumulation of unmetabolized ammonia other mechanisms have been implied as causes of encephalopathy such as imbalance of neurotransmitters, endogenous benzodiazepine ligands, or elevation of circulating tumor necrosis factor (TNF) [19, 20], some of them also involved in the pathogenesis of sepsis-associated delirium .
Besides infection and sepsis surgical complications are the most likely cause of graft dysfunction in the early post-transplant period. Therefore we initiated further diagnostic work-up. Abdominal sonography showed no flow in the hepatic artery and subsequently HAT was confirmed by angiography. During explorative laparotomy the liver was found to be with gross infarction and we decided to evaluate the patient for re-transplantation. Luckily we obtained a graft within 24 hours and after re-transplantation psychosis resolved without sequelae.
We propose that in the described patient HAT is the most likely cause of an acute liver failure although laboratory findings indicated only mild graft dysfunction. Acute liver failure was accompanied by hepatic encephalopathy apparent as acute delusional psychosis.
This case highlights the need to remain suspicious when psychiatric disorders occur in patients after liver transplantation. The diagnostic procedures should not be restricted to medical or neurological causes of psychosis but should also focus vascular complications of OLT.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Stange BJ, Glanemann M, Nuessler NC, Settmacher U, Steinmuller T, Neuhaus P: Hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2003, 9 (6): 612-620. 10.1053/jlts.2003.50098.View ArticlePubMedGoogle Scholar
- Oh CK, Pelletier SJ, Sawyer RG, Dacus AR, McCullough CS, Pruett TL, Sanfey HA: Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. Transplantation. 2001, 71 (6): 767-772. 10.1097/00007890-200103270-00014.View ArticlePubMedGoogle Scholar
- Ikegami T, Hashikura Y, Nakazawa Y, Urata K, Mita A, Ohno Y, Terada M, Miyagawa SI, Kushima H, Kondoh S: Risk factors contributing to hepatic artery thrombosis following living-donor liver transplantation. J Hepatobiliary Pancreat Surg. 2006, 13 (2): 105-109. 10.1007/s00534-005-1015-y.View ArticlePubMedGoogle Scholar
- Goss JA, Shackleton CR, McDiarmid SV, Maggard M, Swenson K, Seu P, Vargas J, Martin M, Ament M, Brill J, Harrison R, Busuttil RW: Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg. 1998, 228 (3): 411-420. 10.1097/00000658-199809000-00014.View ArticlePubMedPubMed CentralGoogle Scholar
- Hatano E, Terajima H, Yabe S, Asonuma K, Egawa H, Kiuchi T, Uemoto S, Inomata Y, Tanaka K, Yamaoka Y: Hepatic artery thrombosis in living related liver transplantation. Transplantation. 1997, 64 (10): 1443-1446. 10.1097/00007890-199711270-00012.View ArticlePubMedGoogle Scholar
- Nikeghbalian S, Kazemi K, Davari HR, Salahi H, Bahador A, Jalaeian H, Khosravi MB, Ghaffari S, Lahsaee M, Alizadeh M, Rasekhi AR, Nejatollahi SMR, Malek-Hosseini SA: Early hepatic artery thrombosis after liver transplantation: diagnosis and treatment. Transplant Proc. 2007, 39 (4): 1195-1196. 10.1016/j.transproceed.2007.02.017.View ArticlePubMedGoogle Scholar
- Pastacaldi S, Teixeira R, Montalto P, Rolles K, Burroughs AK: Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl. 2001, 7 (2): 75-81. 10.1053/jlts.2001.22040.View ArticlePubMedGoogle Scholar
- Soliman T, Bodingbauer M, Langer F, Berlakovich GA, Wamser P, Rockenschaub S, Muehlbacher F, Steininger R: The role of complex hepatic artery reconstruction in orthotopic liver transplantation. Liver Transpl. 2003, 9 (9): 970-975. 10.1053/jlts.2003.50167.View ArticlePubMedGoogle Scholar
- Shaked AA, Takiff H, Busuttil RW: The use of the supraceliac aorta for hepatic arterial revascularization in transplantation of the liver. Surg Gynecol Obstet. 1991, 173 (3): 198-202.PubMedGoogle Scholar
- Adams DH, Ponsford S, Gunson B, Boon A, Honigsberger L, Williams A, Buckels J, Elias E, McMaster P: Neurological complications following liver transplantation. Lancet. 1987, 1 (8539): 949-951. 10.1016/S0140-6736(87)90294-7.View ArticlePubMedGoogle Scholar
- Inouye SK: Delirium in older persons. N Engl J Med. 2006, 354 (11): 1157-1165. 10.1056/NEJMra052321.View ArticlePubMedGoogle Scholar
- Pandharipande P, Jackson J, Ely EW: Delirium: acute cognitive dysfunction in the critically ill. Curr Opin Crit Care. 2005, 11 (4): 360-368.PubMedGoogle Scholar
- Silverstein JH, Timberger M, Reich DL, Uysal S: Central nervous system dysfunction after noncardiac surgery and anesthesia in the elderly. Anesthesiology. 2007, 106 (3): 622-628. 10.1097/00000542-200703000-00026.View ArticlePubMedGoogle Scholar
- The Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 1972, 13 (5): 694-698.View ArticleGoogle Scholar
- Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, Jain A, Alessiani M, Takaya S, Shapiro R: Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg. 1990, 212 (3): 295-305. 10.1097/00000658-199009000-00008.View ArticlePubMedPubMed CentralGoogle Scholar
- Wijdicks EF, Wiesner RH, Dahlke LJ, Krom RA: FK506-induced neurotoxicity in liver transplantation. Ann Neurol. 1994, 35 (4): 498-501. 10.1002/ana.410350422.View ArticlePubMedGoogle Scholar
- Riordan SM, Williams R: Treatment of hepatic encephalopathy. N Engl J Med. 1997, 337 (7): 473-479. 10.1056/NEJM199708143370707.View ArticlePubMedGoogle Scholar
- Lee WM: Acute liver failure. N Engl J Med. 1993, 329 (25): 1862-1872. 10.1056/NEJM199312163292508.View ArticlePubMedGoogle Scholar
- Mullen KD, Martin JV, Mendelson WB, Bassett ML, Jones EA: Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?. Lancet. 1988, 1 (8583): 457-459. 10.1016/S0140-6736(88)91245-7.View ArticlePubMedGoogle Scholar
- Odeh M: Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory. Eur J Clin Invest. 2007, 37 (4): 291-304. 10.1111/j.1365-2362.2007.01778.x.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2482/10/7/prepub